In leukemia, particularly in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), the KMT2A (also known as MLL) gene undergoes translocations with a variety of partner genes, leading to the formation of oncogenic KMT2A fusion proteins [179]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.